CLINICAL TRIALS PROFILE FOR DETROL
✉ Email this page to a colleague
All Clinical Trials for DETROL
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00143481 ↗ | Effect of Detrol LA on Overactive Bladder Symptoms, Sexual Quality of Life and Sexual Function in Women | Completed | Pfizer | Phase 4 | 2005-03-01 | The purpose of the study is to assess the impact of treatment with tolterodine ER versus placebo on Urgency Urinary Incontinence in sexually active women with OAB symptoms. |
NCT00143481 ↗ | Effect of Detrol LA on Overactive Bladder Symptoms, Sexual Quality of Life and Sexual Function in Women | Completed | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Phase 4 | 2005-03-01 | The purpose of the study is to assess the impact of treatment with tolterodine ER versus placebo on Urgency Urinary Incontinence in sexually active women with OAB symptoms. |
NCT00147654 ↗ | Effect and Safety Of Detrol LA In Men With Overactive Bladder Symptoms With Or Without Bladder Outlet Obstruction | Completed | Pfizer | Phase 4 | 2004-11-01 | The primary objective of the trial is to evaluate the effect of tolterodine ER plus tamsulosin versus placebo on patient perception of overall treatment benefit in men who have frequency and urgency, with or without urinary urge incontinence (UUI), with or without bladder outlet obstruction (BOO). |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for DETROL
Condition Name
Clinical Trial Locations for DETROL
Trials by Country
Clinical Trial Progress for DETROL
Clinical Trial Phase
Clinical Trial Sponsors for DETROL
Sponsor Name